fda warning letters glp-1 october 2025 Sends to More Than 50 Compounders and Manufacturers FDA warning letters
Description
Obesity and associated metabolic disorders such as type 2 diabetes mellitus and polycystic ovary syndrome are rising globally, contributing to infertility and adverse pregnancy outcomes
TUESDAY, Aug
The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.
Individual nutritional needs vary
Post-Feb 2026 FDA crackdown, we ranked 8 top GLP-1 programs for women over 40
